Neuroprotective Agent Screening Service
Creative Biolabs, one of the recognized experts in neuroscience research, specializes in applying advanced platforms to a wide range of neuroprotective agent screening studies. With experienced researchers and a complete technical platform, we are committed to providing customers with professional neuroprotective agent screening services for new drugs in the fields of neuroprotection including reactive oxygen species-induced damage, neurodegenerative diseases, learning, and memory.
Overview of Neuroprotective Agent Screening
Neurodegenerative diseases, such as Alzheimer's disease (AD), Parkinson's disease (PD), and multiple sclerosis (MS), are characterized by progressive dysfunction and neuronal death. Neuroprotection is one of the most attractive strategies to mitigate neuronal damage. While neuroprotective agents cannot reverse the damage that has already occurred, they help prevent further nerve damage and slow down the degeneration of the central nervous system (CNS). Thus, neuroprotective agents are closely linked to the treatment of neurodegenerative diseases. In recent years, the development of novel neuroprotective agents has gradually attracted huge drug discovery efforts aimed at providing effective treatment options for various CNS diseases.
Services at Creative Biolabs
Creative Biolabs provides one-stop solutions for nervous system compound screening. We are dedicated to providing screening services for different types of neuroprotective compounds, such as reactive oxygen species-induced damage protective compounds, anti-neurodegenerative drug screening, and neuronal differentiation-promoting compound screening. As a leader in neuroscience, we specialize in providing cell-based tests and animal models to assess the activity and safety of target compounds. In addition, our professional scientists will assist your project by establishing the most suitable screening model according to your project needs.
Fig.1 In vitro assay to screen for neuroprotective drugs. (Martínez, 2021)
Available Models for Neuroprotective Agent Screening
Why Choose Us
- Professional team
Our scientific team has extensive experience in screening neuroprotective compounds and can develop cost-effective screening protocols. Professional scientists provide a strong guarantee of the quality of our services.
- Advanced platform
A variety of cell and animal models suitable for screening neuroprotective compounds, as well as highly configured assay instruments, are available at Creative Biolabs.
- Short cycle
Our customer-oriented multidisciplinary team of experts has built a reputation for high-quality products at competitive costs with fast turnaround times.
- One-stop service
We are confident to provide a one-stop service from project design to final data analysis to speed up your project.
With years of experience focused on neuroscience, Creative Biolabs has built an advanced technology platform. Our platform integrates multiple neuroscience detection and screening services. Our experienced scientists will work with you to customize a sound solution to facilitate the great success of your project. If you are looking for neuroprotective compound screening services or you have any other requirements, please feel free to contact us for more information and a detailed quote.
Reference
- Martínez, A.L.; et al. Development of a novel in vitro assay to screen for neuroprotective drugs against iatrogenic neurite shortening. Plos one. 2021, 16(3): e0248139.
